Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $774.48 million. The enterprise value is $522.86 million.
| Market Cap | 774.48M |
| Enterprise Value | 522.86M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 130.82 million shares outstanding. The number of shares has decreased by -2.37% in one year.
| Shares Outstanding | 130.82M |
| Shares Change (YoY) | -2.37% |
| Shares Change (QoQ) | -1.93% |
| Owned by Insiders (%) | 8.71% |
| Owned by Institutions (%) | 65.39% |
| Float | 105.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 370.37 |
| PS Ratio | 4.01 |
| Forward PS | 3.66 |
| PB Ratio | 1.97 |
| P/FCF Ratio | 1,705.90 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1,151.68 |
Financial Position
The company has a current ratio of 6.97, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.97 |
| Quick Ratio | 5.67 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 24.51 |
| Interest Coverage | -6.59 |
Financial Efficiency
Return on equity (ROE) is -2.90% and return on invested capital (ROIC) is -6.89%.
| Return on Equity (ROE) | -2.90% |
| Return on Assets (ROA) | -2.40% |
| Return on Capital (ROIC) | -6.89% |
| Revenue Per Employee | $285,525 |
| Profits Per Employee | -$17,970 |
| Employee Count | 676 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | -3.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.22% in the last 52 weeks. The beta is 1.37, so CTKB's price volatility has been higher than the market average.
| Beta (1Y) | 1.37 |
| 52-Week Price Change | -39.22% |
| 50-Day Moving Average | 7.25 |
| 200-Day Moving Average | 7.31 |
| Relative Strength Index (RSI) | 34.08 |
| Average Volume (30 Days) | 706,993 |
Short Selling Information
The latest short interest is 9.95 million, so 7.60% of the outstanding shares have been sold short.
| Short Interest | 9.95M |
| Short Previous Month | 8.51M |
| Short % of Shares Out | 7.60% |
| Short % of Float | 9.41% |
| Short Ratio (days to cover) | 11.39 |
Income Statement
In the last 12 months, CTKB had revenue of $193.02 million and -$12.15 million in losses. Loss per share was -$0.09.
| Revenue | 193.02M |
| Gross Profit | 109.43M |
| Operating Income | -27.85M |
| Pretax Income | -15.71M |
| Net Income | -12.15M |
| EBITDA | -4.41M |
| EBIT | -13.64M |
| Loss Per Share | -$0.09 |
Balance Sheet
The company has $262.74 million in cash and $11.13 million in debt, giving a net cash position of $251.61 million or $1.92 per share.
| Cash & Cash Equivalents | 262.74M |
| Total Debt | 11.13M |
| Net Cash | 251.61M |
| Net Cash Per Share | $1.92 |
| Equity / Book Value | 393.06M |
| Book Value Per Share | 3.00 |
| Working Capital | 335.83M |
Cash Flow
In the last 12 months, operating cash flow was $5.28 million and capital expenditures -$4.83 million, giving a free cash flow of $454,000.
| Operating Cash Flow | 5.28M |
| Capital Expenditures | -4.83M |
| Free Cash Flow | 454,000 |
| FCF Per Share | $0.00 |
Margins
Gross margin is 56.69%, with operating and profit margins of -14.43% and -6.29%.
| Gross Margin | 56.69% |
| Operating Margin | -14.43% |
| Pretax Margin | -8.14% |
| Profit Margin | -6.29% |
| EBITDA Margin | -2.28% |
| EBIT Margin | -7.07% |
| FCF Margin | 0.24% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.37% |
| Shareholder Yield | 2.37% |
| Earnings Yield | -1.57% |
| FCF Yield | 0.06% |
Analyst Forecast
The average price target for CTKB is $9.00, which is 52.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.00 |
| Price Target Difference | 52.03% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.61 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.61 |
| Piotroski F-Score | 4 |